Michael Goggins
Scholar

Michael Goggins

Google Scholar ID: TMUOoJ8AAAAJ
Johns Hopkins University
Pancreatic cancer
Citations & Impact
All-time
Citations
34,292
 
H-index
87
 
i10-index
321
 
Publications
20
 
Co-authors
16
list available
Resume (English only)
Academic Achievements
  • Involved in several research projects related to pancreatic cancer, such as the CAPS5 study; Published multiple papers on topics like early detection of pancreatic cancer, familial pancreatic cancer, etc.
Research Experience
  • Serves as the director of the Pancreatic Cancer Early Detection Laboratory, overseeing research that focuses on gene expression patterns of pancreatic cancers using microarray technology, and studying DNA methylation patterns looking for genes that are methylated in pancreatic cancer but not in normal cells.
Education
  • Obtained his medical degree in 1988 from Trinity College of the University of Dublin, Ireland; Completed a residency in internal medicine and a fellowship in Gastroenterology at St. James' Hospital in Dublin; Obtained Membership of the Royal College of Physicians of Ireland in 1991 and European Diploma in Gastroenterology in 1995; Joined the Johns Hopkins faculty in 1999.
Background
  • Professor of Pathology, Medicine and Oncology at the Johns Hopkins University School of Medicine; Director of the Pancreatic Cancer Early Detection Laboratory; Attending Physician in Medicine in the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital; Sol Goldman Professor of Pancreatic Cancer Research. His research interests include developing tests to improve early detection in pancreas cancer, evaluating outcomes of pancreatic surveillance, and identifying gene variants responsible for inherited susceptibility to pancreatic cancer.
Miscellany
  • Male; Sees patients across age groups: Young Adult (18-25), Adult (26-64), Older Adult (65+); Speaks English; Sits on the editorial board of Gut; Affiliated with Johns Hopkins School of Medicine Faculty, Sidney Kimmel Comprehensive Cancer Center, and Sol Goldman Pancreatic Cancer Research Center.